Metraipolis › archive › dc_a1bd0da9de67

Target-Specific Dermatological Adverse Event Reporting With T-Cell-Engaging Bispecific Antibodies: A Pharmacovigilance Analysis of FAERS and Canada Vigilance,… — Europe PMC PMID:42670250

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42670250
DOI
10.1002/cam4.72241
License (as archived)
solo-consultazione
Archived
2026-10-16T12:31:20.608Z
SHA-256 of the archived text
066cdf581b10ecaad0c82b4d4b8926a2c1e81166c1b889e0c0f84abc63348499
Stable URL of this page
https://metraipolis.com/documento/dc_a1bd0da9de67

How to cite

Target-Specific Dermatological Adverse Event Reporting With T-Cell-Engaging Bispecific Antibodies: A Pharmacovigilance Analysis of FAERS and Canada Vigilance,… — Europe PMC PMID:42670250 — Europe PMC (en), https://europepmc.org/article/MED/42670250 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a1bd0da9de67 (Metraipolis archive dc_a1bd0da9de67, sha256 066cdf581b10ecaad0c82b4d4b8926a2c1e81166c1b889e0c0f84abc63348499)
BibTeX
@misc{dca1bd0da9de67,
  title = {Target-Specific Dermatological Adverse Event Reporting With T-Cell-Engaging Bispecific Antibodies: A Pharmacovigilance Analysis of FAERS and Canada Vigilance,… — Europe PMC PMID:42670250},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42670250},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a1bd0da9de67; sha256 066cdf581b10ecaad0c82b4d4b8926a2c1e81166c1b889e0c0f84abc63348499},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42670250. Agents can read the archived copy with the MCP tool read_document.